Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

40.04USD
12 Oct 2018
Change (% chg)

-- (--)
Prev Close
$40.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
689,080
52-wk High
$45.09
52-wk Low
$35.10

Latest Key Developments (Source: Significant Developments)

Hologic To Acquire Focal Therapeutics For $125 Million
Wednesday, 26 Sep 2018 04:01pm EDT 

Sept 26 (Reuters) - Hologic Inc ::HOLOGIC TO ACQUIRE FOCAL THERAPEUTICS FOR $125 MILLION, STRENGTHENING BREAST SURGERY FRANCHISE.HOLOGIC TO ACQUIRE FOCAL THERAPEUTICS FOR $125 MILLION, STRENGTHENING BREAST SURGERY FRANCHISE.HOLOGIC INC - ACQUISITION IS ESTIMATED TO BE NEUTRAL TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE IN FISCAL 2019, AND ACCRETIVE THEREAFTER.HOLOGIC INC - TRANSACTION IS ACCRETIVE TO REVENUE GROWTH RATE AND GROSS MARGIN.  Full Article

Hologic Inc Expects EPS In Q4 To Be At Low End Of Prev Gaap And Non-Gaap Guidance Ranges
Wednesday, 12 Sep 2018 05:10pm EDT 

Sept 12 (Reuters) - Hologic Inc ::HOLOGIC INC - EXPECTS CYNOSURE REVENUE IN CURRENT Q4 TO BE ABOUT $15 MILLION LESS THAN PREVIOUSLY FORECAST.HOLOGIC INC - ESTIMATE INCLUDES LOST SALES OF TEMPSURE VITALIA IN Q4.HOLOGIC INC - REAFFIRMING ITS FINANCIAL GUIDANCE PROVIDED ON JULY 31, 2018.HOLOGIC INC - EXPECTS EPS IN FISCAL Q4 TO BE AT LOW END OF PREVIOUS GAAP AND NON-GAAP GUIDANCE RANGES.HOLOGIC INC - "CANNOT YET PREDICT WHEN IT WILL RESUME SELLING TEMPSURE VITALIA".  Full Article

FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System
Tuesday, 27 Mar 2018 08:06am EDT 

March 27 (Reuters) - Hologic Inc ::FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1).HOLOGIC INC - CLARITY HD HIGH-RESOLUTION 3D IMAGING AND INTELLIGENT 2D IMAGING TECHNOLOGY GOT PMA APPROVAL FROM FDA.  Full Article

Koninklijke Philips And Hologic Announce Global Partnership Agreement
Friday, 2 Mar 2018 03:00am EST 

March 2 (Reuters) - Koninklijke Philips Nv ::PHILIPS AND HOLOGIC ANNOUNCE GLOBAL PARTNERSHIP AGREEMENT TO PROVIDE INTEGRATED IMAGING SOLUTIONS FOR WOMEN'S HEALTH.FINANCIAL DETAILS OF AGREEMENT WERE NOT DISCLOSED.PARTNERSHIP IS A MULTI-YEAR, NON-EXCLUSIVE GLOBAL AGREEMENT.  Full Article

Hologic Reports Q1 GAAP Earnings Per Share $1.45
Thursday, 8 Feb 2018 04:01pm EST 

Feb 8 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018.Q1 NON-GAAP EARNINGS PER SHARE $0.55.Q1 GAAP EARNINGS PER SHARE $1.45.Q1 REVENUE ROSE 7.7 PERCENT TO $791.1 MILLION.REITERATES FULL-YEAR REVENUE GUIDANCE.PERFORMED PRELIMINARY CALCULATIONS AND RECORDED A DISCRETE NET TAX BENEFIT OF $329.2 MILLION IN QUARTER DUE TO TAX CUTS AND JOBS ACT.SEES FY 2018 GAAP EPS $2.36 TO $2.41.SEES 2018 NON-GAAP EPS $2.22 TO $2.27.Q1 EARNINGS PER SHARE VIEW $0.50, REVENUE VIEW $785.9 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $2.20, REVENUE VIEW $3.24 BILLION -- THOMSON REUTERS I/B/E/S.SEES Q2 GAAP EPS $0.27 TO $0.28.SEES Q2 REVENUE $770 MILLION TO $785 MILLION.SEES Q2 GAAP REVENUE $770 MILLION TO $785 MILLION.SEES Q2 NON-GAAP EPS $0.53 TO $0.54.Q2 EARNINGS PER SHARE VIEW $0.53, REVENUE VIEW $790.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Hologic Announces Pricing Of Offering Of $1 Bln Of Senior Notes
Tuesday, 16 Jan 2018 07:40pm EST 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES PRICING OF OFFERING OF $1 BILLION OF SENIOR NOTES.PRICED ‍$600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AT AN ISSUE PRICE OF $1,000 PER $1,000​.‍ PRICED $400 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.625% SENIOR NOTES DUE 2028 AT AN ISSUE PRICE OF $1,000 PER $1,000​.  Full Article

Hologic Announces Offering Of $1 Billion Of Senior Notes
Tuesday, 16 Jan 2018 07:54am EST 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES OFFERING OF $1 BILLION OF SENIOR NOTES.HOLOGIC - LAUNCHED $1 BILLION OF SENIOR NOTES WHICH IS TO BE ALLOCATED BETWEEN ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AND NEW SENIOR NOTES DUE 2028.HOLOGIC SAYS TO USE PROCEEDS OF OFFERING, AVAILABLE CASH TO REDEEM OUTSTANDING $1.0 BILLION 5.25% SENIOR NOTES DUE 2022.  Full Article

Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system
Wednesday, 6 Dec 2017 08:08am EST 

Dec 6 (Reuters) - Hologic Inc ::THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM.HOLOGIC INC - ‍RECEIVED 510(K) CLEARANCE FROM FDA FOR PANTHER FUSION ADV/HMPV/RV ASSAY, A MULTIPLEXED ASSAY THAT RUNS ON NEW PANTHER FUSION SYSTEM​.  Full Article

HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE
Friday, 24 Nov 2017 08:05am EST 

Nov 24 (Reuters) - Hologic Inc ::HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE.HOLOGIC INC- ‍HAS RECEIVED 510(K) CLEARANCE FROM U.S. FOOD AND DRUG ADMINISTRATION FOR QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE​.  Full Article

Hologic announces Q4 GAAP earnings per share $0.29
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - Hologic Inc ::Hologic announces financial results for fourth quarter of fiscal 2017.Q4 non-GAAP earnings per share $0.50.Q4 GAAP earnings per share $0.29.Q4 earnings per share view $0.49 -- Thomson Reuters I/B/E/S.Q4 revenue $802.9 million versus I/B/E/S view $792.5 million.Hologic Inc - ‍expect to post solid, mid-single-digit organic revenue growth in fiscal 2018​.  Full Article

Hologic loses bid to dismiss bioMerieux's HIV test patent case

Diagnostic testing company bioMerieux SA can move forward with a lawsuit alleging that HIV testing kits manufactured by rival Hologic Inc infringe two of its patents, a federal judge in Delaware has ruled.